Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-01-02 3:45 pm Purchase | 13G | AVENUE THERAPEUTICS INC NE ATXI | SABBY MANAGEMENT LLC | 661,056 11% | 397,056 (+150.40%) | View |
2024-01-02 3:34 pm Sale | 13G | BONE BIOLOGICS CORP BBLG | SABBY MANAGEMENT LLC | 9,877 11% | -1,227,328 (-99.20%) | View |
2024-01-02 3:10 pm Sale | 13G | ADITXT INC ADTX | SABBY MANAGEMENT LLC | 22,048 11% | -393,649 (-94.70%) | View |
2024-01-02 2:02 pm Sale | 13G | NEPTUNE WELLNESS SOLUTIONS INC NEPT | SABBY MANAGEMENT LLC | 452,751 11% | -643,162 (-58.69%) | View |
2024-01-02 1:45 pm Purchase | 13G | TOUGHBUILT INDS INC TBLT | SABBY MANAGEMENT LLC | 1,842,070 11% | 610,650 (+49.59%) | View |
2024-01-02 1:31 pm Sale | 13G | DOGNESS INTL CORP COM DOGZ | SABBY MANAGEMENT LLC | 63,636 11% | -2,015,147 (-96.94%) | View |
2024-01-02 1:13 pm Sale | 13G | BLUE WATER BIOTECH, INC BWV | SABBY MANAGEMENT LLC | 930,905 11% | -279,781 (-23.11%) | View |
2024-01-02 10:24 am Sale | 13G | NISUN INTL ENTERPRISE DEV GROU NISN | SABBY MANAGEMENT LLC | 0 0% | -3,147,362 (Position Closed) | View |
2024-01-02 10:11 am Sale | 13G | VIRPAX PHARMACEUTICALS INC VRPX | SABBY MANAGEMENT LLC | 0 0% | -988,165 (Position Closed) | View |
2024-01-02 09:53 am Sale | 13G | COCRYSTAL PHARMA INC COCP | SABBY MANAGEMENT LLC | 0 0% | -420,710 (Position Closed) | View |
2024-01-02 09:42 am Sale | 13G | PULMATRIX INC PULM | SABBY MANAGEMENT LLC | 182,249 11% | -119,689 (-39.64%) | View |
2023-01-10 3:53 pm Sale | 13G | AGM GROUP HLDGS INC USD O AGMH | SABBY MANAGEMENT LLC | 627,936 11% | -865,501 (-57.95%) | View |
2023-01-10 3:15 pm Sale | 13G | CINGULATE INC CING | SABBY MANAGEMENT LLC | 564,340 11% | -321,914 (-36.32%) | View |
2023-01-10 2:47 pm Sale | 13G | CONTEXT THERAPEUTICS INC CNTX | SABBY MANAGEMENT LLC | 796,706 11% | -434,124 (-35.27%) | View |
2023-01-10 2:35 pm Sale | 13G | TANTECH HLDGS LTD TANH | SABBY MANAGEMENT LLC | 41,500 11% | -6,146,297 (-99.33%) | View |
2023-01-10 2:21 pm Sale | 13G | HEARTBEAM INC BEAT | SABBY MANAGEMENT LLC | 271,788 11% | -211,532 (-43.77%) | View |
2023-01-10 2:10 pm Sale | 13G | RECON TECHNOLOGY, LTD. CLASS A RCON | SABBY MANAGEMENT LLC | 1,482,066 11% | -1,211,639 (-44.98%) | View |
2023-01-10 1:49 pm Sale | 13G | BIT DIGITAL, INC. BTBT | SABBY MANAGEMENT LLC | 3,166,917 11% | -1,048,935 (-24.88%) | View |
2023-01-10 1:36 pm Purchase | 13G | VIRPAX PHARMACEUTICALS INC VRPX | SABBY MANAGEMENT LLC | 988,165 11% | 111,331 (+12.70%) | View |
2023-01-10 11:57 am Purchase | 13G | PHARMACYTE BIOTECH INC PMCB | SABBY MANAGEMENT LLC | 934,456 11% | 673,528 (+258.13%) | View |